FibroGen Inc

NASDAQ:FGEN 4:00:00 PM EDT

5.30

+0.08 (+1.53%)

5:45:40 PM EDT: $5.05 -0.25 (-4.72%)

Market Cap (Intraday)	21.75M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.88 Million
Adjusted EPS	-$2.25

See more estimates

10-Day MA	$5.65
50-Day MA	$7.32
200-Day MA	$9.55

See more pivots

FibroGen Inc Stock, NASDAQ:FGEN

350 Bay Street, Suite 100-6009, San Francisco, California 94133

United States of America

Phone: +1.415.978.1200

Number of Employees: 486

http://www.fibrogen.com

Description

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.